Eli Lilly’s Point Biopharma acquisition would not change our optimism on the diabetes-and-obesity drug big heading into the new yr.
Source link
Eli Lilly completes small buy of cancer drugmaker — the payoff may come later
Byomshreeinfotech
Dec 28, 2023